Gino Santini

CIK: 0001276038

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (12.5%)

Position reduction

Option Exercises (M)2 (25.0%)

Derivative conversions

Awards (A)5 (62.5%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

COLL

COLLEGIUM PHARMACEUTICAL, INC

Director

CMPS

COMPASS Pathways plc

Director

Discretionary Trading P&L

Holdings

Transaction History (8 total)

COLL
COLLEGIUM PHARMACEUTICAL, INC
Jun 8, 2026
Exercise(M)
Direct
8.7K shares at avg. $16.49$143K
CMPS
COMPASS Pathways plc
May 27, 2026
Award(A)
Share Option (Right to Buy)
Direct
30.2K shares-
COLL
COLLEGIUM PHARMACEUTICAL, INC
May 14, 2026
Award(A)
Direct
8.7K shares-
COLL
COLLEGIUM PHARMACEUTICAL, INC
Aug 15, 2025
Exercise(M)
Direct
15K shares at avg. $13.45$202K
COLL
COLLEGIUM PHARMACEUTICAL, INC
Aug 15, 2025
Sale(S)
Direct
5.4K shares at avg. $37.19$201K
CMPS
COMPASS Pathways plc
Jun 12, 2025
Award(A)
Share Option (Right to Buy)
Direct
39K shares-
COLL
COLLEGIUM PHARMACEUTICAL, INC
May 15, 2025
Award(A)
Direct
9.8K shares-
CMPS
COMPASS Pathways plc
Sep 3, 2024
Award(A)
Share Option (Right to Buy)
Direct
52K shares-

		Type	Shares	Price		Ownership
Jun 8, 2026	COLL COLLEGIUM PHARMACEUTICAL, INC	Exercise(M)	8,700	$16.49	$143,463	Direct
May 27, 2026	CMPS COMPASS Pathways plc	Award(A) Share Option (Right to Buy)	30,158	-	-	Direct
May 14, 2026	COLL COLLEGIUM PHARMACEUTICAL, INC	Award(A)	8,741	-	$0	Direct
Aug 15, 2025	COLL COLLEGIUM PHARMACEUTICAL, INC	Exercise(M)	15,000	$13.45	$201,750	Direct
Aug 15, 2025	COLL COLLEGIUM PHARMACEUTICAL, INC	Sale(S)	5,405	$37.19	$201,018	Direct
Jun 12, 2025	CMPS COMPASS Pathways plc	Award(A) Share Option (Right to Buy)	39,000	-	-	Direct
May 15, 2025	COLL COLLEGIUM PHARMACEUTICAL, INC	Award(A)	9,791	-	-	Direct
Sep 3, 2024	CMPS COMPASS Pathways plc	Award(A) Share Option (Right to Buy)	52,000	-	-	Direct

1-8 of 8 transactions

About SANTINI GINO

SANTINI GINO (SEC CIK 0001276038) files insider reports with the SEC as Director of COLLEGIUM PHARMACEUTICAL, INC (COLL) and Director of COMPASS Pathways plc (CMPS).

Signal8 holds 8 ownership filings by SANTINI GINO (1 Form 3, 7 Form 4), filed between Sep 4, 2024 and Jun 10, 2026. Those filings report 8 transactions, from Sep 3, 2024 to Jun 8, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on SANTINI GINO's filings is in STOUGHTON, MA.

Recent filings by SANTINI GINO

Jun 8, 2026: Option exercise of COLL shares (Form 4, code M).
May 27, 2026: Grant or award of CMPS derivative securities (Form 4, code A).
May 14, 2026: Grant or award of COLL shares (Form 4, code A).
Aug 15, 2025: Option exercise of COLL shares (Form 4, code M).
Aug 15, 2025: Open-market sale of COLL shares (Form 4, code S).

Other insiders filing for COLLEGIUM PHARMACEUTICAL, INC (COLL)

How to read Form 4 transaction codes